Skip to main content
Log in

Narrow-band UVB plus corticosteroid cost effective for vitiligo

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2017 British pounds

Reference

  • Sach TH, et al. An economic evaluation of the randomised controlled trial of topical corticosteroid and home-based narrowband UVB for active and limited vitiligo (The HI-Light Trial). British Journal of Dermatology : 12 Sep 2020. Available from: URL: http://doi.org/10.1111/bjd.19554

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Narrow-band UVB plus corticosteroid cost effective for vitiligo. PharmacoEcon Outcomes News 863, 23 (2020). https://doi.org/10.1007/s40274-020-7177-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-7177-7

Navigation